Yi Xin is the founder of Beijing Gene+ Technology. Beijing Gene+ Technology has raised $220M in total funding. Latest round: Series D.
Yi Xin is a co-founder of Beijing Gene+ Technology, a company established in 2015. Beijing Gene+ Technology operates in the precision medicine and oncology diagnostics market, providing gene sequencing and detection services for cancer research and treatment. The company has secured significant venture capital backing, with its latest Series C funding round in July 2021 raising $116 million, and a Series D round raising $42.4 million in December 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library